UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
42,833,193
Total 13F shares
43,119,761
Share change
-1,311,448
Total reported value
$9,315,950,531
Put/Call ratio
46%
Price per share
$216.08
Number of holders
409
Value change
-$262,053,365
Number of buys
173
Number of sells
214

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2021

As of 31 Dec 2021, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 409 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,119,761 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, and FULLER & THALER ASSET MANAGEMENT, INC.. This page lists 409 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.